Drug Shortage Report for ATROPINE SULFATE INJECTION USP

Last updated on 2022-04-27 History
Report ID 159096
Drug Identification Number 00392693
Brand name ATROPINE SULFATE INJECTION USP
Common or Proper name ATROPINE SO4
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ATROPINE SULFATE
Strength(s) .6MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 1ML 10LIAM
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-04-20
Actual start date
Estimated end date 2022-07-08
Actual end date
Shortage status Actual shortage
Updated date 2022-04-27
Company comments Product is available on allocation at wholesalers, based on 100% of historical volumes.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-04-27 French Compare
v6 2022-04-27 English Compare
v5 2022-04-20 French Compare
v4 2022-04-20 English Compare
v3 2022-04-20 French Compare
v2 2022-04-20 French Compare
v1 2022-04-20 English Compare

Showing 1 to 7 of 7